U.S. Diseases

Verastem Reported Positive Drug Trial Results

The pharmaceutical company announced promising trial data and a $250 million stock offering.

Live Poll

Is now a good time for individual investors to buy shares in speculative biotech companies?

The leader of the Catholic Church had his lower right lung lobe removed following a lung adenocarcinoma diagnosis.

Live Poll

Do you trust pharmaceutical trial data as a reliable indicator of a company's long-term value?

The company confirmed the success of its TRiM delivery platform through early-stage trial data for an Alzheimer’s therapy.

Live Poll

Do you prefer when television adaptations follow original books closely?

The third season of the supernatural series, titled Anne Rice's Mayfair Witches: Salem Coven, arrives this December.

Live Poll

Should the development of new genetic treatments for rare diseases be prioritized despite the inherent risks?

The Phase 1/2 trial for ENTR-601-45 met safety objectives in the first cohort of study participants.

Live Poll

Should the federal government prioritize data detail over cost savings in national health surveys?

The federal government plans to halve the number of questions in its long-running National Health Interview Survey.